BML Inc
BML, Inc. provides contract clinical testing and related services in Japan. The company offers a range of laboratory testing, such as biochemical and hematologic examination; laboratory test, including tumor markers, infectious diseases, hormones, cellular immunity, genetics, bacteriological tests, and other test; specialized testing in oncology, infectious diseases, diabetes, hypertension, aller… Read more
BML Inc (BMZ) - Total Liabilities
Latest total liabilities as of September 2025: €43.81 Billion EUR
Based on the latest financial reports, BML Inc (BMZ) has total liabilities worth €43.81 Billion EUR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
BML Inc - Total Liabilities Trend (2016–2025)
This chart illustrates how BML Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
BML Inc Competitors by Total Liabilities
The table below lists competitors of BML Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Cantor Equity Partners IV, Inc. Class A Ordinary Shares
NASDAQ:CEPF
|
USA | $72.33K |
|
ACNB Corporation
NASDAQ:ACNB
|
USA | $2.81 Billion |
|
Metsa Board Corp. Series B
LSE:0O7A
|
UK | €1.12 Billion |
|
CHINA OVERSEAS (SWL.SG)
STU:SWL
|
Germany | €89.35 Billion |
|
Aegean Airlines S.A
PINK:AGZNF
|
USA | $2.59 Billion |
|
Rami Levi Chain Stores Hashikma Marketing 2006 Ltd
PINK:RLEVF
|
USA | $4.00 Billion |
|
Esso Thailand PCL
STU:JAV
|
Germany | €36.69 Billion |
Liability Composition Analysis (2016–2025)
This chart breaks down BML Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.61 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.35 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.25 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how BML Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for BML Inc (2016–2025)
The table below shows the annual total liabilities of BML Inc from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | €43.74 Billion | +7.06% |
| 2024-03-31 | €40.85 Billion | -3.18% |
| 2023-03-31 | €42.20 Billion | -26.64% |
| 2022-03-31 | €57.52 Billion | +24.90% |
| 2021-03-31 | €46.05 Billion | +28.45% |
| 2020-03-31 | €35.85 Billion | +2.89% |
| 2019-03-31 | €34.84 Billion | +4.88% |
| 2018-03-31 | €33.22 Billion | -1.11% |
| 2017-03-31 | €33.60 Billion | -1.73% |
| 2016-03-31 | €34.19 Billion | -- |